|
|
|
|
 |
|
Human
Genome News Archive Edition |
|
|
Sponsored
by the U.S. Department of
Energy Human Genome Program
|
| Available
in PDF In this issue... Genome Project In the News Microbial Genomics Proteomics Genetics in Medicine Web, Other Resources, Publications Funding Meeting Calendars & Acronyms |
Proteomics NewsTool for Protein AnalysisPEDANT is a software system for completely automatic and exhaustive analysis of protein sequence sets, from individual sequences to complete genomes. This server now contains 20 complete genomic sequences and 1 plasmid, as well as 21 experimental and unfinished genomic sequences. Entries for completed genomes include three sections:
TREMBL Release 6Release 6 of TREMBL, a protein sequence database that supplements SWISS-PROT, has been announced. TREMBL contains the translations of all EMBL Nucleotide Sequence Database coding sequences not yet integrated into SWISS-PROT. Weekly TREMBL updates are available by anonymous ftp and from the Sequence Retrieval System server of the European Bioinformatics Institute. [Contact: apweiler@ebi.ac.uk]R&D 100 Award to LANL's SOLVEOne of the four R&D 100 awards won by Los Alamos National Laboratory in 1998 was for SOLVE, a system that produces 3-D pictures of protein structure. SOLVE automatically carries out all the steps necessary to fill in missing information in X-ray crystallography, a process that uses X rays to determine the structure of atoms, ions, or molecules in chemical substances. SOLVE's speed and ease of operation make it suitable for the rapid analysis of protein molecule shapes, and accurate protein pictures can be produced in hours rather than days. In addition, the automated system can evaluate hundreds of solutions and can be operated by a novice. SOLVE shows promise in helping researchers design new and improved drugs, enzymes for rapidly breaking down toxic waste or synthesizing useful chemicals, and heat-tolerant enzymes useful in chemical manufacturing processes.Technologies funded by DOE accounted for 34 of the 100 R&D awards in 1998. [SOLVE Contact: Thomas Terwilliger 505/667-0072] NIH Proteomics Grant to AxysAxys Pharmaceuticals Inc. of South San Francisco, California, has been awarded a Phase I Small Business Innovation Research grant from the NIH National Institute of General Medical Sciences to conduct a 6-month research study of proteomics. Proteomics is the global search for and identification and prediction of protein function. The Axys goal is to build the ProteomeBank, a software system and proprietary database of protein families for high-throughput, accurate prediction of protein function.Completing the E. coli ProteomeA database of genes characterized since completion of the Escherichia coli genome sequence lists new and old gene names, SWISS-PROT entry, gene location, genetic structure, and identified function.The electronic form of the newsletter may be cited in the following style: |
Send the url of this page to a friend
Last modified: Wednesday, October 29, 2003
Home * Contacts * Disclaimer
Base URL: www.ornl.gov/hgmis
Site sponsored by the U.S. Department of Energy
Office of Science, Office
of Biological and Environmental Research, Human
Genome Program
